Skip to main content

Currently Skimming:

Appendix C New Classes of Antimicrobials Workshop
Pages 69-78

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 69...
... , Harvard Medical School Michael G Kurilla, Director, Office of Biodefense Research Affairs, National Institute of Allergy and Infectious Diseases, NIH Workshop Participants 69
From page 70...
... Break 3:20 p.m. Molecular Detection and Diagnosis: The Role of Detection and Rapid Diagnosis in Treating Infectious Disease Francis Barany, Weill Medical College of Cornell University 3:50 p.m.
From page 71...
... APPENDIX C 71 4:15 p.m. Small group discussions to organize topics for Tuesday breakout sessions 5:00 p.m.
From page 72...
... Participants · Rustom Antia, Emory University · Francis Barany, Weill Medical College of Cornell University · Bonnie L Bassler, Princeton University (member of committee)
From page 73...
... Barry Sharpless, The Scripps Research Institute · Peter M Small, Bill and Melinda Gates Foundation · Anne Summers, University of Georgia · Joyce Sutcliffe, Rib-X Pharmaceuticals · Saeed Tavazoie, Princeton University · Julie Theriot, Stanford University · Christopher T
From page 74...
... Upon appointment as an Assistant Professor in Microbiology at Weill Medical College of Cornell University in 1985, he was named a Cornell Scholar in Biomedical Sciences, and in 1992 received a five year Hirschl/Monique Weill-Caulier Career Scientist Award. He currently holds the rank of Full Professor in the Department of Microbiology and Program of Biochemistry and Structural Biology at Cornell/Sloan Kettering Institute.
From page 75...
... Dr. Moellering has authored more than 350 publications and is Editor-in-Chief Emeritus of Antimicrobial Agents and Chemotherapy, Editor of Infectious Disease Clinics of North America and Editor of the European Journal of Clinical Microbiology and Infectious Diseases.
From page 76...
... , and been involved in scientific advisory capacity for Genzyme, Immunogen, Leukosite, Kosan Biosciences, Millennium, Versicor, Transform Pharmaceuticals, Critical Therapeutics, and MPM capital. He sits on the Board of Directors of Critical Therapeutics, Kosan, Microbia, and Vicuron.
From page 77...
... APPENDIX C 77 partment of Biochemistry at McMaster in 1993. He holds a Canada Research Chair in Antibiotic Biochemistry and has received Canadian Institutes of Health Research Scientist (2000-2005)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.